The Food and Drug Administration could authorize Covid-19 boosters from Pfizer Inc. and BioNTech SE for use in 16- and 17-year olds as soon as next week as concerns rise over the possible spread of a new, possibly more transmissible variant, according to a person familiar with the planning.

The agency is planning to move rapidly to take action on a request by the companies to authorize boosters for 16- and-17 year olds, according to a person familiar with the matter. So far, only people 18 years and older are eligible for boosters.

This post first appeared on wsj.com

You May Also Like

Crypto giant FTX to file for bankruptcy, CEO Sam Bankman-Fried steps down

Crypto giant FTX and its affiliated companies have started the process of…

U.S. Won’t Hit Borrowing Limit Until Second Half of 2023

This copy is for your personal, non-commercial use only. Distribution and use…

HarperCollins to Buy Houghton Mifflin’s Trade Publishing Unit

“Global demand for books — print and digital — has never been…

Peloton, Pizza and Videogames Grow in Stay-at-Home World

Consumers holed up during the coronavirus pandemic redirected their travel and entertainment…